Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy
Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy
复制标题
DOI:
10.1016/j.ejps.2009.11.010
复制
发表时间:
2010-01-31
影响因子:
4.6
通讯作者:
Sahoo, Sanjeeb K.
中科院分区:
文献类型:
--
作者:
Misra, Ranjita;Sahoo, Sanjeeb K.
Doxorubicin (DOX) is an anticancer drug with an intracellular site of action in the nucleus. For high antitumour activity, it should be effectively internalized into the cancer cells and accumulate in the nucleus. In this study, we have prepared a nuclear localization signal conjugated doxorubicin loaded Poly (D,L-lactide-co-glycolide) nanoparticles (NPs), to deliver doxorubicin to the nucleus efficiently. Physicochemical characterization of these NPs showed that the drug is molecularly dispersed in spherical and smooth surfaced nanoparticles. NPs (similar to 226 nm in diameter, 46% encapsulation efficiency) under in vitro conditions exhibited sustained release of the encapsulated drug (63% release in 60 days). Cell cytotoxicity results showed that NLS conjugated NPs exhibited comparatively lower IC50 value (2.3 mu M/ml) than drug in solution (17.6 mu M/ml) and unconjugated NPs (7.9 mu M/ml) in breast cancer cell line MCF-7 as studied by MTT assay. Cellular uptake studies by confocal laser scanning microscopy (CLSM) and fluorescence spectrophotometer showed that greater amount of drug is targeted to the nucleus with NLS conjugated NPs as compared to drug in solution or unconjugated NPs. Flow cytometry experiments results showed that NLS conjugated NPs are showing greater cell cycle (G2/M phase) blocking and apoptosis than native DOX and unconjugated NPs. In conclusion, these results suggested that NLS conjugated doxorubicin loaded NPs could be potentially useful as novel drug delivery system for breast cancer therapy. (C) 2009 Elsevier B.V. All rights reserved.